Downloadable Slides From Immunotherapy in Multiple Myeloma: Emerging Strategies
prIME Downloadable Slides
prIME Downloadable Slides

Downloadable Slides From Immunotherapy in Multiple Myeloma: Emerging Strategies

Not a member of My prIME? Join now for instant access.

If you missed our immunotherapy symposium in New Delhi, download the meeting slides and see what our expert faculty covered at Immunotherapy in Multiple Myeloma: Emerging Strategies, held in conjunction with the 16th International Myeloma Workshop.

Downloadable Slides

Downloadable Slides

Release Date

Release Date

Mar 5, 2017

Expiration Date

Mar 5, 2018

Featured Expert

  • Darrell White, MD, MSc FRCPC, FACP, Dalhousie University, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada

Featured Topic

Immunotherapy in multiple myeloma (MM): Where we are now

Featured Expert

  • Jeffrey Zonder, MD, Karmanos Cancer Institute, Detroit, Michigan, United States

Featured Topic

Examining strategies to tailor immunotherapy to the patient with MM

Featured Expert

  • Alexander Lesokhin, MD, Memorial Sloan Kettering Cancer Center, New York, New York, United States

Featured Topic

The biology behind immunotherapy in MM and its implications for the future

Featured Expert

  • Alexander Lesokhin, MD, Memorial Sloan Kettering Cancer Center, New York, New York, United States

Featured Topic

prIME Points™

After successful completion of this educational activity, participants should be able to:

  • Describe current novel immunotherapy options in relapsed/refractory (R/R) MM
  • Tailor/individualize immunotherapy in MM to disease burden and biology
  • Explain the biology behind immunotherapy in R/R MM and the future of immunotherapeutic approaches

This educational activity is supported by a grant from Bristol-Myers Squibb.

Enduring Materials From a Certified Activity

This enduring material, derived from a certified live event, contains content that is evidence-based, balanced, and free of commercial bias. While the content was planned and implemented by prIME Oncology for a certified live event, this activity does not offer continuing education credit.

Provider

This activity is provided by prIME Oncology.